VivoSim Labs, INC. (VIVS)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for VivoSim Labs, INC.. Most notable: 2026-07-17: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-27 | Cohen Douglas Jay | director | A | 15,000 | 0 | $0 |
| 2026-01-27 | Murphy Keith | director | A | 15,000 | 0 | $0 |
| 2026-01-27 | Milhous Alison Tjosvold | director | A | 15,000 | 0 | $0 |
| 2026-01-27 | Gobel David | director | A | 15,000 | 0 | $0 |
| 2026-01-27 | STERN ADAM K | director | A | 15,000 | 0 | $0 |
| 2025-11-17 | Gobel David | director | S | 3,266 | 2.24 | $7,316 |
| 2024-08-07 | Gobel David | director | A | 19,607 | 0 | $0 |
| 2024-08-07 | Cohen Douglas Jay | director | A | 19,607 | 0 | $0 |
| 2024-08-07 | Milhous Alison Tjosvold | director | A | 19,607 | 0 | $0 |
| 2024-08-07 | Joshi Vaidehi | director | A | 19,607 | 0 | $0 |
| 2024-08-07 | STERN ADAM K | director | A | 19,607 | 0 | $0 |
| 2024-08-07 | Murphy Keith | director | A | 19,607 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-01 4
- 2026-08-21 ARS
- 2026-08-21 8-K
- 2026-08-21 DEF 14A
- 2026-08-17 SCHEDULE 13G/A
- 2026-08-13 PRER14A
- 2026-08-12 10-Q
- 2026-08-10 EFFECT
- 2026-08-10 PRE 14A
- 2026-08-06 8-K
- 2026-07-31 S-1
- 2026-07-30 8-K
- 2026-07-24 8-K
- 2026-07-17 8-K
- 2026-07-14 10-K
- 2026-06-29 NT 10-K
- 2026-04-06 SCHEDULE 13G
- 2026-04-03 8-K
- 2026-04-02 424B4
- 2026-03-31 EFFECT